PDCD1 and neoplasm: The combination of PD-L1 and PD-1 can induce T cell apoptosis, disability, and depletion (Figure 2), thereby inhibiting the activation, proliferation, and anti-tumor function of tumor antigen-specific CD8+ T cells and achieving tumor immune escape (32–39).